Lymphoma
This year, an estimated 66,670 people in the United States will be diagnosed with lymphoma. These include 7,800 cases of Hodgkin's disease and 58,870 cases of non-Hodgkin's lymphoma.
Treatments for these disorders vary and may include radiation therapy, chemotherapy, high-dose chemoradiotherapy and/or blood and marrow transplantation. These treatments have helped increase the 5-year survival rate to 85 percent for Hodgkin's disease and 60 percent for non-Hodgkin's lymphoma.
Blood and marrow transplantation offers the greatest hope for patients who are at high risk, or who have relapsed. The Transplant Program at UH has significant expertise and experience in the treatment of lymphoma in this manner. Clinical trials are exploring new antibody treatments, various chemotherapy regimens, and targeted therapies.
The Lymphoma Patient Care Team meets weekly to review cases and design individualized treatment programs that incorporate the latest therapies and technologies.
A comprehensive patient education and support program works to support these patients throughout their disease management.
Meet the Leukemia Care Team: